Tumor xenografts experiments suggested that silencing PVT1 sensitized NSCLC (Non-small-cell lung carcinoma) cells to radiotherapy in vivo, and this could be reverted by miR-195 inhibitor (41). This evidence concerns the gene PVT1 and neoplasm.